Status:
RECRUITING
Telerehabilitation in Patients With Idiopathic Pulmonary Fibrosis
Lead Sponsor:
Istanbul Medipol University Hospital
Conditions:
IPF
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
It is to determine the effectiveness of different telerehabilitation exercise programs received to 2 groups randomly formed in idiopathic pulmonary fibrosis (IPF) patients. The cases meeting the inclu...
Detailed Description
Patients diagnosed with idiopathic pulmonary fibrosis by a chest diseases specialist and referred to pulmonary rehabilitation will be included in the study. The cases meeting the inclusion criteria wi...
Eligibility Criteria
Inclusion
- Being between the ages of 18-75
- Having a diagnosis of IPF disease diagnosed according to the following clinical diagnostic criteria according to the American Thoracic and European Respiratory Societies (ATS-ERS)
- Presence of dyspnea on exertion
- Stable clinical state at the time of admission without infection or exacerbation in the previous 4 weeks
Exclusion
- Patients with severe comorbid diseases, unstable coronary artery disease, collagen vascular diseases and needing high flow oxygen therapy (˃ 3-4 L \\min).
- A history of effort-related syncope or any comorbidity (such as severe orthopedic or neurological deficits or unstable heart disease) that precludes exercise training.
- Participation in a pulmonary rehabilitation program within the past 12 months.
Key Trial Info
Start Date :
November 26 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2026
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT05190211
Start Date
November 26 2021
End Date
August 1 2026
Last Update
November 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yedikule Chest Disease Hospital
Istanbul, Zeytinburnu, Turkey (Türkiye), 34200